Elevated plasma homocysteine (Hcy) is associated with cerebrovascular disease and activates matrix metalloproteinases (MMPs), which lead to vascular remodeling that could disrupt the blood-brain barrier. To determine if Hcy administration can increase brain microvascular leakage secondary to activation of MMPs, we examined pial venules by intravital video microscopy through a craniotomy in anesthetized mice.
INTRODUCTION
Homocysteine (Hcy) is a toxic, non-protein sulfur containing amino acid that is formed exclusively upon demethylation of methionine. Hcy is nutritionally regulated and metabolized through remethylation, or trans-sulfuration pathways. Total plasma content of Hcy varies from 3 to 15 µM and higher plasma levels are called hyperhomocysteinemia (HHcy). The ranges of HHcy have been referred to as: moderate (16 to 30 µM), intermediate (31 to 100 µM) or severe (> 100 µM) (12) .
Recent data indicate that moderate HHcy is an independent risk factor for several cardiovascular and cerebrovascular disorders including atherosclerosis (12, 13, 44) , vascular thrombosis (38) , diabetes (1), Alzheimer's and Parkinson's diseases (28, 44) and stroke (39, 44, 47) . However, some studies point to a lesser role of Hcy in development of atherosclerosis in human coronary arteries (23) . Other work (31) suggests that essential hypertension may be associated with increased plasma Hcy levels and indicate that it is unrelated to endothelial damage (assessed by the plasma von Willebrand factor) and clinical indices or prognosis. Discrepancies in associating Hcy with vascular damage may be due to variations in the criteria used to determine the role of Hcy in various cardiovascular and cerebrovascular disorders and suggest a lack of systemic functional studies.
Many cerebrovascular disorders are accompanied by alterations in the blood brain barrier that result in microvascular leakage and edema formation. Therefore, the vascular endothelium has a key role in these processes. We (21) , and others (7) showed that enhanced formation of filamentous actin (F-actin) in endothelial cells is associated with increased gap formation between the cells that could result in microvascular leakage. In the present study, we investigated the role of acute HHcy on cerebrovascular leakage. We tested the hypothesis that high plasma Hcy levels can mediate macromolecular leakage in mouse brain pial microvessels via activation of matrix metalloproteinases (MMPs) and increased formation of F-actin in endothelial cells. The results of this study suggest that Hcy has a significant role in development of microvascular leakage, and that this process can be drastically ameliorated by inhibition of MMPs.
MATERIALS AND METHODS
In accordance of with National Institute of Health Guidelines for animal research, all animal procedures for these experiments were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Louisville.
Animals and microvascular observation of pial vascular bed
Male, wild-type (WT) C57BL/6J or MMP-9 gene-knockout (MMP-9 -/-) mice (28-32 g) were anesthetized with tribromoethanol (240 mg/kg; ip.), and a tracheal cannula was inserted to maintain a patent airway. Body temperature was kept at 37 ± 1 °C with a heating pad. Mean arterial blood pressure (MABP) and pulse rate were continuously monitored through a catheter (PE10) inserted into a carotid artery and connected to a transducer and a blood pressure analyzer (Micro-Med, Louisville, KY).
Brain pial microcirculation was prepared for observations similarly to the methods described by others (11, 17, 32) . Briefly, the scalp and connective tissues were removed over the parietal cranial bone above the left hemisphere. A craniotomy was done with a small trephine attached to a high-speed micro-drill (Fine Science Tool, Foster City, CA).
During the drilling, the cranium was continuously washed with room temperature physiological salt solution (PSS). The dura was reflected with the bone disk using a micro-rongeur with extra-fine tips (Fine Science Tool, Foster City, CA) to form a cranial window about 3 mm in diameter. From this time, the exposed brain surface and pial circulation were bathed continuously by applying oxygenated artificial cerebrospinal fluid (ASCF, composition: 132 mM NaCL, 2.95 mM KCL, 1.71 mM CaCL, 1.4 mM MgSO 4 , 24.6 mM NaHCO 3 , 3.71 mM Glucose, 6.7 mM Urea) with pH 7.4 and temperature of 37°C. Others have found that responses of pial vessels observed from an opened cranial window are generally representative of the responses of the pial microcirculation (30, 31) .
Microvascular leakage observation.
Hcy-induced microvascular leakage was observed according to a method described previously (36) . The animals were positioned on the stage of a Nikon MM-11 trinocular microscope so that the exposed pial circulation could be observed by epiillumination. After the surgical preparation there was a one hour equilibration period.
Before each experiment, autofluorescence of the observed area was recorded over a standard range of camera gains. Then, fluorescein isothiocyanate (FITC, 300 µg/ml) (24) tagged to bovine serum albumin (BSA, Sigma Chemicals Co. St. Louis, MO) was injected intra-arterially (0.2 ml/100g of body wt.) and allowed to circulate for about 10 min. The pial circulation was surveyed to ensure that there was no spontaneous leakage in the observed area that would indicate compromised vascular integrity. An epi-illumination system, consisting of a mercury arc lamp and a ploem system with appropriate filters, was used to excite intravascular fluorescein isothiocyanate. The area of interest was exposed to blue light (450-490 nm) for 10-15 sec with a power density of 2 J/cm 2 . The microscope images were acquired by a light sensitive silicon intensified tube camera (Hamamatsu C2400) and image acquisition system (Marvel G450-eTV, Matrox Graphics Inc., Canada). The camera output voltage was standardized with a 50 ng/ml fluorescein diacetate standard (Estman Kodak, Rochester, NY) for each experiment. The magnification of the system was determined by a stage micrometer and vessel diameters were measured directly on the video monitor using a video caliper.
The separate groups of animals (3 WT mice treated with PSS, 3 WT mice treated with Hcy and 3 MMP-9 -/-mice treated with Hcy) were anesthetized with sodium pentobarbital (65 mg/kg body wt. IP). One milliliter of blood was collected from the vena cava of the anesthetized WT and MMP-9 -/-mice as described earlier (18, 19) . Then, animals were overdosed (euthanized) with sodium pentobarbital (100 mg/kg body wt.
IP) and brain samples were collected and frozen for subsequent MMP analyses. Blood was centrifuged at 4000xg for 5 min. After centrifugation, the Hcy level was determined in plasma samples from WT and MMP-9-/-mice according to the method described earlier (46).
Determination of macromolecular leakage
A fluorescein diacetate standard curve was determined (25) Hcy-induced formation of F-actin fibers and total fluorescence intensity were assessed for each well by analyzing 3 random fields with image analysis software (Image-Pro Plus, Media Cybernetics). The data were obtained in duplicate (two wells per experimental group) and averaged for each experimental group described above.
The results were expressed as FIU.
Gelatin zymography.
Activity of MMP-2 and MMP-9 were measured in brain cortical tissue homogenates and in FITC-BSA solution treated with active MMP-9. Zymography was performed on 1% gelatin SDS-PAGE. The lytic activity was scanned and normalized to total protein of samples loaded into each lane of the gel as described previously (45) .
Data are presented as light intensity units (LIU).
Data analysis
Data are expressed as mean ± SE. To compare the groups before and after treatment, one way repeated measures analysis of variance (ANOVA) was used.
Differences in means were compared by the Tukey test and considered statistically significant if p< 0.05.
RESULTS

Macromolecular leakage from Pial venules
During baseline before injection of Hcy or vehicle (PSS), MABP and pulse rate were similar in WT (88 ± 3 mm Hg, 385 ± 15 bpm; n=5) and MMP-9 -/-(85 ± 3 mm Hg, 381 ± 13 bpm; n=4) mice. Forty minutes after Hcy injection, MABP and pulse rate did not change significantly in these WT (79 ± 6 mm Hg, 415 ± 26 bpm) and MMP-9 -/-(77 ± 5 mm Hg, 418 ± 22 bpm), mice. In separate WT (n=5) and MMP-9 -/-(n=3) mice, baseline MABP and pulse rate (84 ± 5 mm Hg, 397 ± 15 bpm in WT, and 86 ± 6 mm Hg, 381 ± 16 bpm) also did not change significantly after injection of PSS (86 ± 4 mm Hg, 380 ± 12 bpm in WT; 83 ± 4 mm Hg, 376 ± 11 bpm in MMP-9 -/-). In a different group of MMP-9-/-mice (n=4), 40 min after topical application of histamine, MABP and pulse rate were similar to baseline (81 ± 5mm Hg vs 84 ± 3 mm Hg and 393 ± 11 bpm vs 387 ± 9 bpm). Similarly, in WT mice (n=4), topical application of histamine did not cause changes in MABP (89 ± 4 mm Hg vs 86 ± 5 mm Hg at baseline) or pulse rate (382 ± 10 bpm vs 393 ± 11 bpm at baseline).
Macromolecular leakage significantly increased in WT mice after Hcy administration (Fig. 1) . Leakage was noticeable 5 min after Hcy injection and became greater after 40 min (Fig. 1) . Injection of PSS did not cause leakage in WT mice over the same time course (Fig. 1) . During these observations, in the WT mice, baseline venular diameters (36 ± 5 µm) were not different 40 min after Hcy injection (40 ± 6 µm).
In a separate group of WT mice, baseline venular diameters (34 ± 3 µm) were also not different 40 min after PSS administration (32 ± 5 µm).
When Hcy was injected into MMP-9 -/-mice (n=4) it did not cause venular leakage (Fig. 1) . Similarly, injection of PSS in MMP-9 -/-mice did not cause leakage (110 ± 7 FIU at baseline, 118 ± 4 FIU after 5 min and 124 ± 6 FIU after 40 min). Venular diameters were the same before and 40 min after injection of Hcy (30 ± 2 µm vs 33 ± 4 µm). Injection of PSS in MMP-9 -/-mice also did not change venular diameters (32 ± 4 µm vs 32 ± 5 µm).
In MMP-9-/-mice group (n=4) treated with topical application of histamine, venular leakage was significantly increased (112 ± 4 FIU at baseline to 127 ± 3 FIU after 5 min, and to 145 ± 5 FIU after 40 min). In WT mice (n=4) topical application of histamine increased fluorescence intensity by a similar extent (106 ± 8 FIU at baseline to 112 ± 6 FIU after 5 min, and to 141 ± 7 FIU after 40 min). Venular diameters in MMP-9-/-mice were similar before and 40 min after histamine application (34 ± 4 µm vs 37 ± 5 µm). In WT mice, venular diameters increased significantly from 33 ± 7 µm (baseline) to 40 ± 6 µm after histamine application.
Effect of MMP-9 on stability of FITC-BSA conjugate
There was no detectable cleavage of albumin by activated MMP-9 ( Fig. 2A) . The presence of active MMP-9 in our FITC-BSA samples was confirmed by gelatin zymography (Fig. 2B) .
Effect of Hcy on formation of MMP-2 and MMP-9
Activities of MMP-2 and MMP-9 were significantly increased in brain tissue samples collected from the separate group of WT mice after 40 min of Hcy injection, compared to samples collected from a group of untreated mice (Fig. 3) . As expected, formation of MMP-9 was not noticeable in brain tissue samples from MMP-9 gene knockout mice, and there were no significant changes in formation of MMP-2 (Fig. 3A) .
Furthermore, activities of MMP-2 and MMP-9 were not altered in brain tissue samples from WT mice after injection of PSS (69 ± 4 and 82 ± 6 LIU respectively; n=3) compared to the MMP-2 and MMP-9 activities in samples from untreated mice (65 ± 4 and 84 ± 3 LIU respectively; n=3).
The level of plasma Hcy in WT and MMP-9 -/-mice.
Plasma levels of Hcy in WT (3.2 ± 0.2 µM; n=3) and MMP-9-/-(4.8 ± 1.2 µM; n=3) mice were in the normal range (12) . We (21) and others (6) found that increased formation of F-actin leads to gap formation in the endothelial cell layer. Gap formation is suggested as one of the reasons for macromolecular vascular leakage in response to inflammatory stimuli (7, 21) .
Increased expression of MMP-9 in endothelial cells has been implicated during development of cerebral stroke, which has been significantly reduced after selective inhibition of MMP-9 (29) . A significant role of MMPs in formation of F-actin has also been demonstrated by others (6, 33) . These data suggest that formation of MMPs may result in enhanced formation of endothelial F-actin leading to macromolecular leakage. Our study compared Hcy effects in age-matched mice that underwent similar surgical preparations. Vascular permeability was assessed by comparing fluorescence intensity values measured in a similar size AOI in the interstitum next to a venule before and after treatment. Since each animal served as its own control, small differences in baseline permeability are unlikely to account for the changes in permeability in response to the agonists (34) . In MMP-9-/-and WT mice, histamine induced similar microvascular leakage compared to baseline values. However, it was significantly less than that induced by Hcy in WT mice (Fig. 1) . Our data show that cerebral vessels of MMP-9 -/-mice have the ability to leak in response to an inflammatory agent, and that this leakage occurs independently of an MMP-9-involved mechanism. Study of mechanisms of the histamine-induced leakage and vascular responses are beyond the scope of the present investigation. A limitation of this study is that the ability of histamine to cross an intact arachnoid is controversial, and could be related to damage the meninges when the dura was removed. For example, Sarker et al. (34) , who removed the arachnoid with the dura in juvenile rats, clearly showed that topical application of histamine at doses ≥ 50 µM reduced cerebrovascular permeability. However, in other studies topical application of 10 -4 M histamine (the dose used in our study) increased cerebrovascular permeability in rats (2, 3, 22, 27, 48) , cats (35) , and mice (49).
In conclusion, our study shows for the first time that an acute increase in blood Thus, the present study suggests yet another destructive role of Hcy, and a possible pathway of its effect on venular permeability changes in brain pial circulation. Values are means ± SE. * P < 0.05 vs. control at the same time. Values are means ± SE. * P < 0.05 vs. control.
n=3 for all groups. Values are means ± SE. * P < 0.05 vs. control; † P < 0.05 vs. Hcy-treated.
n=4 for all groups.
